Menu
GWAS Study

Multiancestry exome sequencing reveals INHBE mutations associated with favorable fat distribution and protection from diabetes.

Akbari P, Sosina OA, Bovijn J et al.

35999217 PubMed ID
GWAS Study Type
618375 Participants
51 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

AP
Akbari P
SO
Sosina OA
BJ
Bovijn J
LK
Landheer K
NJ
Nielsen JB
KM
Kim M
AS
Aykul S
DT
De T
HM
Haas ME
HG
Hindy G
LN
Lin N
DI
Dinsmore IR
LJ
Luo JZ
HS
Hectors S
GB
Geraghty B
GM
Germino M
PL
Panagis L
PP
Parasoglou P
WJ
Walls JR
HG
Halasz G
AG
Atwal GS
JM
Jones M
LM
LeBlanc MG
SC
Still CD
CD
Carey DJ
GA
Giontella A
OM
Orho-Melander M
BJ
Berumen J
KP
Kuri-Morales P
AJ
Alegre-Díaz J
TJ
Torres JM
EJ
Emberson JR
CR
Collins R
RD
Rader DJ
ZB
Zambrowicz B
MA
Murphy AJ
BS
Balasubramanian S
OJ
Overton JD
RJ
Reid JG
SA
Shuldiner AR
CM
Cantor M
AG
Abecasis GR
FM
Ferreira MAR
SM
Sleeman MW
GV
Gusarova V
AJ
Altarejos J
HC
Harris C
EA
Economides AN
IV
Idone V
KK
Karalis K
DG
Della Gatta G
MT
Mirshahi T
YG
Yancopoulos GD
MO
Melander O
MJ
Marchini J
TR
Tapia-Conyer R
LA
Locke AE
BA
Baras A
VN
Verweij N
LL
Lotta LA
Chapter II

Abstract

Summary of the research findings

Body fat distribution is a major, heritable risk factor for cardiometabolic disease, independent of overall adiposity. Using exome-sequencing in 618,375 individuals (including 160,058 non-Europeans) from the UK, Sweden and Mexico, we identify 16 genes associated with fat distribution at exome-wide significance. We show 6-fold larger effect for fat-distribution associated rare coding variants compared with fine-mapped common alleles, enrichment for genes expressed in adipose tissue and causal genes for partial lipodystrophies, and evidence of sex-dimorphism. We describe an association with favorable fat distribution (p = 1.8 × 10-09), favorable metabolic profile and protection from type 2 diabetes (~28% lower odds; p = 0.004) for heterozygous protein-truncating mutations in INHBE, which encodes a circulating growth factor of the activin family, highly and specifically expressed in hepatocytes. Our results suggest that inhibin βE is a liver-expressed negative regulator of adipose storage whose blockade may be beneficial in fat distribution-associated metabolic disease.

458,317 European ancestry individuals, 138,792 Hispanic or Latin American individuals, 8,948 African ancestry individuals, 2,203 East Asian ancestry individuals, 10,115 South Asian ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

618375
Total Participants
GWAS
Study Type
No
Replicated
European, Hispanic or Latin American, African unspecified, East Asian, South Asian
Ancestry
Sweden, U.K., Mexico
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.